Modelling suggests blood group incompatibility may substantially reduce SARS-CoV-2 transmission
View ORCID ProfilePeter Ellis
doi: https://doi.org/10.1101/2020.07.13.20152637
Peter Ellis
1University of Kent School of Biosciences, Stacey Building, Canterbury, KENT, UK, CT2 7NZ
Article usage
Posted July 14, 2020.
Modelling suggests blood group incompatibility may substantially reduce SARS-CoV-2 transmission
Peter Ellis
medRxiv 2020.07.13.20152637; doi: https://doi.org/10.1101/2020.07.13.20152637
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)